Matrix metalloproteinases and their inhibitors in gastric cancer

Gut

Volumn 43, Issue 6, 1998, Pages 791-797

  Murray, G I ^a   Duncan, M E ^a   Arbuckle, E ^a   Melvin, W T ^a   Fothergill, J E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Immunohistochemistry; Matrix metalloproteinase; Neoplasm; Stomach

Indexed keywords

COLLAGENASE; FORMALDEHYDE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PARAFFIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; CANCER INVASION; CONTROLLED STUDY; EMBEDDING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; STOMACH CANCER; TISSUE FIXATION; TISSUE SECTION;

EID: 0031769534     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.6.791     Document Type: Article

References (39)

1. Morson BC, Dawson IMP, Day DW, et al. Morson and Dawson's gastrointestinal pathology, 3rd edn. Oxford: Blackwell Science, 1990:53-70.
2. Hart IR, Saini A. Biology of tumour metastasis. Lancet 1992;339:1453-7.
3. Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995;55:1856-62.
4. Murphy G, Docherty AJP. The matrix metalloproteinases and their inhibitors. Am J Resp Cell Mol Biol 1992;7:120-5.
5. Stetler-Stevenson WG, Liotta LA, Kliener DE. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 1993;7:1434-41.
6. Davies B, Waxman J, Wasan H, et al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 1993;53:5365-9.
7. Boag AH, Young ID. Increased expression of the 72-kD type IV collagenase in prostate adenocarcinoma. Am J Pathol 1994;144:585-91.
8. Muller D, Wolf C, Abecassis J, et al. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinoma. Cancer Res 1993;53:165-9.
9. Urbanski SJ, Edwards DR, Hershfield N, et al. Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diagn Mol Pathol 1993;2:81-9.
10. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991;5:2145-54.
11. Tryggvason K, Höyhtä M, Pyke M. Type IV collagenases in invasive tumors. Breast Cancer Res Treat 1993;24:209-18.
12. Sato H, Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem 1996;119: 209-15.
13. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994;370:61-5.
14. Denhardt DT, Feng B, Edwards DR, et al. Tissue inhibitor of metalloproteinases (TIMP, akaEPA): structure, control of expression and biological functions. Pharmacol Ther 1993;59:329-41.
15. Cawston TE. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther 1996; 70:163-82.
16. Uria JA, Ferrando AA, Velasco G, et al. Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res 1994;54:2091-4.
17. Greene J, Wang MS, Liu YLE, et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996;271:30375-80.
18. Douglas DA, Shi YE, Sang QA. Computational sequence analysis of the tissue inhibitor of metalloproteinase family. J Prot Chem 1997;16:237-55.
19. Gomis-Ruth F-X, Maskos K, Betz M, et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 1997;389:77-81.
20. Albini A, Melchiori A, Santi L, et al. Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 1991;83:775-9.
21. Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996;2:461-2.
22. Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 1998;185:256-61.
23. Sambrook J, Fritsch KF, Maniatis T. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1989.
24. Hiraga A, Kemp, BE, Cohen P. Further studies on the structure of the glycogen-bound form of protein phosphatase-1 from rabbit skeletal muscle. Eur J Biochem 1987;163:253-8.
25. Duncan ME, McAleese SM, Booth NA, et al. A simple enzyme-linked immunosorbent assay (ELISA) for the neuron-specific γ isozyme of human enolase (NSE) using monoclonal antibodies raised against synthetic peptides corresponding to isozyme sequence differences. J Immunol Meth 1992;151:227-36.
26. Matsudaira P. Sequence from picomole of protein electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 1987;262:10035-8.
27. Murphy G, Docherty AJP, Hembry RM, et al. Research in arthritis: cellular events in osteoarthritis. Br J Rheumatol 1991;30(suppl 1):25-31.
28. Murray GI, Duncan ME, Melvin WT, et al. Immunohistochemistry of neuron specific enolase with gamma-subunit specific anti-peptide monoclonal antibodies. J Clin Pathol 1993;46:993-6.
29. David L, Nesland JM, Holm R, et al. Expression of laminin, collagen IV, fibronectin and type IV collagenase in gastric carcinoma. Cancer 1994;73:518-27.
30. Nomura H, Fujimoto N, Seike M, et al. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer (Pred Oncol) 1996;69:9-16.
31. Kawano X, Osawa H, Ito T, et al. Expression of gelatinase A, tissue inhibitor of metalloproteinase-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study. Hum Pathol 1997;28:613-22.
32. Höyhtyä M, Fridman R, Komarek D, et al. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissue with monoclonal antibodies. Int J Cancer 1994;56:500-5.
33. Schwarz G, Wang H, Lampen K, et al. Defining the invasive phenotype of proximal gastric cells. Cancer 1994;73:22-7.
34. Sier CFM, Kubben FJGM, Ganesh S, et al. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 1996;74:413-17.
35. Watanabe M, Takahashi Y, Ohta T, et al. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice. Cancer 1996;77(suppl):1676-80.
36. Watson SA, Morris TM, Robinson G, et al. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res 1995;55:3629-33.
37. Sledge GW, Qulali M, Goulet R, et al. Effects of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst 1995;87:1546-50.
38. Brown PD, Giavazzi R. Matrix metalloproteinase inhibition: a review of anti-tumour activity. Ann Oncol 1995;6:967-74.
39. Hua J, Muschel RJ. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res 1996;56:5279-84.